Connect your AI

Esperion Therapeutics ESPR Total Assets

Total Assets at other companies

AmgenAMGN

$92.5B+3.5%

Regeneron PharmaceuticalsREGN

$40.87B+8.9%

NewAmsterdam Pharma CompanyNAMS

$732.64M-10.5%

Lexicon PharmaceuticalsLXRX

$268.82M-9.7%

Eton Pharmaceuticals, Inc.ETON

$97.71M+16.3%

Zevra Therapeutics, Inc.ZVRA

$278.58M+61.3%

Other financials

Income statement

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Cash flow

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Esperion Therapeutics's total assets?: Esperion Therapeutics (ESPR) reported total assets of $462.53M in Q1 2026.
How has Esperion Therapeutics's total assets changed year-over-year?: Esperion Therapeutics's total assets increased by 42.7% year-over-year, from $324.03M to $462.53M.
What is the long-term trend for Esperion Therapeutics's total assets?: Over 5 years (2020 to 2025), Esperion Therapeutics's total assets has grown at a 5.7% compound annual growth rate (CAGR), from $353.26M to $465.89M.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.